Oppenheimer & Co’s Inogen INGN Stock Holding History
Bought
Maintained
Sold
Other funds holding INGN
BCM
NHAS
FAM
WRF
Oppenheimer & Co's INGN Position: Q2 2019 in Review
Oppenheimer & Co sold out of Inogen (INGN) in Q2 2019, closing a stake of 6,768 shares — an estimated $646K sold.
Oppenheimer & Co first reported a position in INGN in Q1 2014 and held it in 21 quarters. The position peaked at $1.49M in Q3 2018. 197 funds tracked by Wall St. Rank hold INGN as of Q2 2019.
- Oppenheimer & Co reported no remaining Inogen position as of Q2 2019 after selling out during the quarter.
- Oppenheimer & Co sold 6,768 Inogen shares in Q2 2019, an estimated $646K.
- Oppenheimer & Co first reported a position in Inogen in Q1 2014 and held it in 21 quarters.
- Oppenheimer & Co's Inogen position peaked at $1.49M in Q3 2018.
- 197 funds tracked by Wall St. Rank held Inogen as of Q2 2019.
Based on Oppenheimer & Co's 13F filing for Q2 2019, filed 9 Aug 2019.